(Q40145522)

17 September 2017

title

Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells (English)

1 reference

17 September 2017

Marjan Gharagozloo

1

1 reference

17 September 2017

Zahra Amirghofran

series ordinal

2

1 reference

17 September 2017

publication date

14 April 2007

1 reference

Journal of Cancer Research and Clinical Oncology

17 September 2017

published in

1 reference

17 September 2017

volume

133

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

525-532

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-007-0197-x

17 September 2017

exact match

0 references

cites work

Silibinin: a thorny therapeutic for EGF-R expressing tumors?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0197-X

Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0197-X

Using chemopreventive agents to enhance the efficacy of cancer therapy

21 January 2018

1 reference

12 December 2020

Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers

1 reference

12 December 2020

Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.

1 reference

12 December 2020

The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer

1 reference

12 December 2020

Silibinin protects mice from T cell-dependent liver injury

1 reference

12 December 2020

Stimulatory effect of Silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other malign cell lines

1 reference

12 December 2020

Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients

1 reference

12 December 2020

Prostate cancer chemoprevention by silibinin: bench to bedside

1 reference

12 December 2020

Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay

1 reference

12 December 2020

Immunostimulatory effect of Silybum Marianum (milk thistle) extract

1 reference

12 December 2020

Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.

1 reference

12 December 2020

Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells

1 reference

12 December 2020

Silybin and silymarin--new effects and applications

1 reference

12 December 2020

Thiol-inducing and immunoregulatory effects of flavonoids in peripheral blood mononuclear cells from patients with end-stage diabetic nephropathy

1 reference

12 December 2020

Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.

1 reference

12 December 2020

Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication.

1 reference

12 December 2020

Potential synergism of natural products in the treatment of cancer

1 reference

12 December 2020

Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy

1 reference

12 December 2020

Hepatoprotective and immunomodulatory effects of antioxidant therapy

1 reference

12 December 2020

Anticancer drug targets: cell cycle and checkpoint control.

1 reference

12 December 2020

Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin.

1 reference

12 December 2020

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression

1 reference

12 December 2020

The epidermal growth factor receptor family

1 reference

12 December 2020

The antitumor activities of flavonoids

1 reference

12 December 2020

Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers

1 reference

12 December 2020

Silymarin: a review of its clinical properties in the management of hepatic disorders

1 reference

12 December 2020

Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase C.

1 reference

12 December 2020

Toward a core nutraceutical program for cancer management

1 reference

12 December 2020

Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells

1 reference

12 December 2020

Silybin inhibition of human T-lymphocyte activation

1 reference

12 December 2020

Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway.

1 reference

12 December 2020

Molecular targets of dietary agents for prevention and therapy of cancer

1 reference

12 December 2020

Natural flavonoids targeting deregulated cell cycle progression in cancer cells.

1 reference

12 December 2020

10.1007/S00432-007-0197-X

Identifiers

DOI

1 reference

17 September 2017

1 reference